Glyxambi 10 mg/5 mg film-coated tablets *

  • Company:

    Boehringer Ingelheim Limited
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form EU/1/16/1146/001-009 10/5 milligram(s) A10BD,A10BD19 Film-coated tablet